Equity Overview
Price & Market Data
Price: $0.013
Daily Change: $0.00 / 0.00%
Daily Range: $0.013 - $0.013
Market Cap: $1,817,363
Daily Volume: 100,000
Performance Metrics
1 Week: 16.43%
1 Month: 1.88%
3 Months: -23.74%
6 Months: -33.33%
1 Year: -46.67%
YTD: -23.74%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.